September 10, 2025

Launch of the ADAPT trial – evaluating a blood test for Alzheimer’s disease

The Blood Biomarker Challenge is a multi-million-pound programme supported by Alzheimer’s Society, Alzheimer’s Research UK and the People’s Postcode Lottery and aims to find out whether a blood test can be used as part of diagnosis for Alzheimer’s disease. ADAPT is one of the two trials involved in the Blood Biomarker Challenge.

This test has already shown promising results and has the benefit of being less invasive and expensive than current biomarker tests such as amyloid PET scans and lumbar punctures. An accurate and accessible blood test would be a game changer. Come and hear from the co-leads of the trial as they begin recruiting their first participants into this study. We also have representatives from Alzheimer’s Research UK and Alzheimer’s Society who will speak to why this current test looks so promising, the importance of developing a blood test for Alzheimer’s, and how it could potentially revolutionise Alzheimer’s diagnosis and treatment in the NHS.

Speakers included:

Professor Jonathan Schott, Professor of Neurology at University College London and ADAPT trial co-lead

Dr Ashvini Keshavan, Senior Clinical Research Fellow and Honorary Consultant Neurologist at the Dementia Research Centre, UCL Queen Square Institute of Neurology and trial co-lead

Dr Sheona Scales, Director of Research, Alzheimer’s Research UK

Professor Fiona Carragher, Chief Policy and Research Officer, Alzheimer’s Society